Harsh Impex Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-12-2024
- Paid Up Capital ₹ 2.38 M
as on 06-12-2024
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 06-12-2024
- Revenue -22.72%
(FY 2023)
- Profit -201.30%
(FY 2023)
- Ebitda -486.16%
(FY 2023)
- Net Worth -9.07%
(FY 2023)
- Total Assets 3.89%
(FY 2023)
About Harsh Impex
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.38 M.
The company currently has active open charges totaling ₹2.00 Cr.
Parsan Chindalia, Megha Golchha, and Meena Golchha serve as directors at the Company.
- CIN/LLPIN
U17299WB1985PTC038796
- Company No.
038796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Harsh Impex Pvt Ltd offer?
Harsh Impex Pvt Ltd offers a wide range of products and services, including Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Harsh Impex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parsan Chindalia  | Director | 26-Feb-2007 | Current |
| Megha Golchha | Director | 21-Jan-2017 | Current |
| Meena Golchha | Director | 10-Jan-2017 | Current |
Financial Performance and Corporate Structure Insights of Harsh Impex.
Harsh Impex Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.72% decrease. The company also saw a substantial fall in profitability, with a 201.3% decrease in profit. The company's net worth dipped by a decrease of 9.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harsh Impex?
In 2023, Harsh Impex had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Trans Indo Logistics Private LimitedActive 16 years 2 months
Parsan Chindalia and Meena Golchha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 04 Apr 2008 | ₹2.00 Cr | Open |
How Many Employees Work at Harsh Impex?
Unlock and access historical data on people associated with Harsh Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harsh Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harsh Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
